FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017642150> ?p ?o ?g. }

• W2017642150 endingPage "99" @default.
• W2017642150 startingPage "91" @default.
• W2017642150 abstract "It remains unclear if certain antiretroviral medications, particularly abacavir, compromise response to HCV therapy. Such data could inform the selection of appropriate antiretrovirals in HIV/HCV-coinfected patients. The aim of this study was to determine if use of abacavir, as well as other antiretrovirals, was associated with reduced response to pegylated interferon (PEG-IFN) plus ribavirin.A cohort study was performed among antiretroviral-treated HIV/HCV-coinfected patients initiating PEG-IFN plus ribavirin between January 2001 and June 2007 at six sites in the United States. Abacavir and other antiretrovirals represented exposures of interest. Study outcomes included an early virological response (> or =2 log IU/ml decrease in HCV viral load at 12 weeks) and sustained virological response (undetectable HCV viral load 24 weeks after treatment discontinuation).Among 212 patients, 74 (35%) received abacavir. For patients infected with HCV genotype 1 or 4, no differences were observed between abacavir users and non-users in early virological response (26 [40%] versus 53 [44%]; adjusted odds ratio [OR] 1.00; 95% confidence interval [CI] 0.50-2.00) or sustained virological response (8 [13%] versus 13 [12%]; adjusted OR 1.34; 95% CI 0.50-3.62). Among genotype 2 and 3 patients, rates of early virological response (7 [78%] versus 16 [89%]; OR 0.44; 95% CI 0.05-3.76) and sustained virological response (3 [33%] versus 8 [44%]; OR 0.63; 95% CI 0.12-3.32) were also similar between abacavir users and non-users. No association was found between other antiretrovirals and a lack of early or sustained response.Use of abacavir or other antiretroviral medications was not associated with reduced early or sustained virological response rates." @default.
• W2017642150 created "2016-06-24" @default.
• W2017642150 creator A5007948313 @default.
• W2017642150 creator A5013318234 @default.
• W2017642150 creator A5032536542 @default.
• W2017642150 creator A5036887186 @default.
• W2017642150 creator A5038404989 @default.
• W2017642150 creator A5055096822 @default.
• W2017642150 creator A5065954575 @default.
• W2017642150 creator A5068543626 @default.
• W2017642150 creator A5079749370 @default.
• W2017642150 date "2010-01-01" @default.
• W2017642150 modified "2023-09-27" @default.
• W2017642150 title "The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients" @default.
• W2017642150 cites W105889878 @default.
• W2017642150 cites W1966927243 @default.
• W2017642150 cites W1972879932 @default.
• W2017642150 cites W1978988374 @default.
• W2017642150 cites W1993484328 @default.
• W2017642150 cites W1996434966 @default.
• W2017642150 cites W2040351784 @default.
• W2017642150 cites W2047208492 @default.
• W2017642150 cites W2058519026 @default.
• W2017642150 cites W2066704301 @default.
• W2017642150 cites W2094174828 @default.
• W2017642150 cites W2097073538 @default.
• W2017642150 cites W2104641446 @default.
• W2017642150 cites W2113864802 @default.
• W2017642150 cites W2121595515 @default.
• W2017642150 cites W2140881716 @default.
• W2017642150 cites W2142434090 @default.
• W2017642150 cites W2182777591 @default.
• W2017642150 cites W2394721885 @default.
• W2017642150 cites W4318600583 @default.
• W2017642150 cites W83931366 @default.
• W2017642150 doi "https://doi.org/10.3851/imp1492" @default.
• W2017642150 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2854539" @default.
• W2017642150 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20167995" @default.
• W2017642150 hasPublicationYear "2010" @default.
• W2017642150 type Work @default.
• W2017642150 sameAs 2017642150 @default.
• W2017642150 citedByCount "26" @default.
• W2017642150 countsByYear W20176421502012 @default.
• W2017642150 countsByYear W20176421502013 @default.
• W2017642150 countsByYear W20176421502014 @default.
• W2017642150 countsByYear W20176421502015 @default.
• W2017642150 countsByYear W20176421502016 @default.
• W2017642150 countsByYear W20176421502018 @default.
• W2017642150 crossrefType "journal-article" @default.
• W2017642150 hasAuthorship W2017642150A5007948313 @default.
• W2017642150 hasAuthorship W2017642150A5013318234 @default.
• W2017642150 hasAuthorship W2017642150A5032536542 @default.
• W2017642150 hasAuthorship W2017642150A5036887186 @default.
• W2017642150 hasAuthorship W2017642150A5038404989 @default.
• W2017642150 hasAuthorship W2017642150A5055096822 @default.
• W2017642150 hasAuthorship W2017642150A5065954575 @default.
• W2017642150 hasAuthorship W2017642150A5068543626 @default.
• W2017642150 hasAuthorship W2017642150A5079749370 @default.
• W2017642150 hasBestOaLocation W20176421501 @default.
• W2017642150 hasConcept C126322002 @default.
• W2017642150 hasConcept C142462285 @default.
• W2017642150 hasConcept C156957248 @default.
• W2017642150 hasConcept C159047783 @default.
• W2017642150 hasConcept C203014093 @default.
• W2017642150 hasConcept C2522874641 @default.
• W2017642150 hasConcept C2776408679 @default.
• W2017642150 hasConcept C2776455275 @default.
• W2017642150 hasConcept C2776461080 @default.
• W2017642150 hasConcept C2778715236 @default.
• W2017642150 hasConcept C2779465607 @default.
• W2017642150 hasConcept C2780040827 @default.
• W2017642150 hasConcept C2993143319 @default.
• W2017642150 hasConcept C3013748606 @default.
• W2017642150 hasConcept C44249647 @default.
• W2017642150 hasConcept C71924100 @default.
• W2017642150 hasConcept C90924648 @default.
• W2017642150 hasConceptScore W2017642150C126322002 @default.
• W2017642150 hasConceptScore W2017642150C142462285 @default.
• W2017642150 hasConceptScore W2017642150C156957248 @default.
• W2017642150 hasConceptScore W2017642150C159047783 @default.
• W2017642150 hasConceptScore W2017642150C203014093 @default.
• W2017642150 hasConceptScore W2017642150C2522874641 @default.
• W2017642150 hasConceptScore W2017642150C2776408679 @default.
• W2017642150 hasConceptScore W2017642150C2776455275 @default.
• W2017642150 hasConceptScore W2017642150C2776461080 @default.
• W2017642150 hasConceptScore W2017642150C2778715236 @default.
• W2017642150 hasConceptScore W2017642150C2779465607 @default.
• W2017642150 hasConceptScore W2017642150C2780040827 @default.
• W2017642150 hasConceptScore W2017642150C2993143319 @default.
• W2017642150 hasConceptScore W2017642150C3013748606 @default.
• W2017642150 hasConceptScore W2017642150C44249647 @default.
• W2017642150 hasConceptScore W2017642150C71924100 @default.
• W2017642150 hasConceptScore W2017642150C90924648 @default.
• W2017642150 hasIssue "1" @default.
• W2017642150 hasLocation W20176421501 @default.
• W2017642150 hasLocation W20176421502 @default.
• W2017642150 hasLocation W20176421503 @default.
• W2017642150 hasLocation W20176421504 @default.

• next